INTERNATIONAL STRATEGIC HEALTHCARE COMMUNICATIONS

Experienced, trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, digital health, biotech and healthcare services, large & small.

WHAT WE DO

COMMUNICATING A COMPELLING GROWTH STORY TO THE INVESTMENT COMMUNITY

Effectively communicating a company’s strategy, growth ambitions, and the reasons to “invest now” is critical for management teams as they seek to build investor confidence and support. We have an exceptional track record in advising globally on healthcare fund raisings, IPOs and M&A transactions.

FIND OUT MORE

Insights & Latest News

#FuturaMedical ($FUM) are featured in @IChronicle

Simon Thompson discussing Futura’s MED2005 entering Phase III and the impact on share prices.

To read the full article visit https://t.co/xjLAf8SNZP #biotech #SexualHealth #ED #MensHealth #MED2005

Sickle Cell Disease is a serious inherited blood disorder where the red blood cells develop abnormally. @Masters_SP is the exclusive distributor of Siklos in the UK and Brazil, and proud to supply high quality medicines for rare diseases. #SickleCellAwarenessMonth

SAVE THE DATE

11th Optimum Healthcare Investor Conference

17th October 2019 | LONDON

MEET US THERE

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH